2025
SJR Q1
JCR Q2 · 3,1
68 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Vascular and Interventional Radiology
- Yayıncı
- Elsevier Inc.
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
1051044315357732
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,885
- Quartile Q1
- H-Index 154
- Atıf/yayın 1,93
- Doküman (3y) 1.048
- Atıf (3y) 1.945
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,1
- 5Y JIF 3
- JCI 0,71
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Cardiology and Cardiovascular Medicine Q2
- Medicine (miscellaneous) Q2
- Radiology, Nuclear Medicine and Imaging Q1
Alanlar
- Medicine
WoS kategorileri
- Radiology, Nuclear Medicine & Medical Imaging | Peripheral Vascular Diseases
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,885 | 3,1 | 3 | 0,71 | Q2 | 154 |
| 2024 | Q2 | Q2 | 0,646 | 2,6 | 2,8 | 0,65 | Q2 | 150 |
| 2023 | Q2 | Q2 | 0,767 | 2,6 | 3,2 | 0,65 | Q2 | 150 |
| 2022 | Q1 | Q2 | 0,804 | 2,9 | 3,3 | 0,68 | Q2 | 150 |
| 2021 | Q1 | Q2 | 0,914 | 3,7 | 4 | 0,76 | Q2 | 150 |
| 2020 | Q1 | Q2 | 0,979 | 3,5 | 3,7 | 0,77 | Q2 | 150 |
| 2019 | Q1 | Q2 | 0,942 | 3 | 3,1 | 0,77 | Q2 | 150 |
| 2018 | — | Q2 | — | 2,8 | 2,9 | 0,76 | Q2 | — |
| 2017 | Q1 | Q2 | 1,209 | 2,8 | 3,1 | 0,79 | Q2 | 150 |
| 2016 | Q1 | Q2 | 1,167 | 2,8 | 2,9 | — | — | 150 |
| 2015 | Q1 | Q2 | 1,236 | 2,6 | 2,5 | — | — | 150 |
| 2014 | Q1 | Q2 | 1,109 | 2,4 | 2,4 | — | — | 150 |
| 2013 | Q1 | Q2 | 1,106 | 2,1 | 2,2 | — | — | 150 |
| 2012 | Q1 | Q2 | 1,197 | 2 | 2,1 | — | — | 150 |
| 2011 | Q1 | Q2 | 1,167 | 2,1 | 2,3 | — | — | 150 |
| 2010 | Q1 | Q2 | 1,171 | 2,1 | 2,4 | — | — | 150 |
| 2009 | — | Q2 | — | 1,8 | 2,4 | — | — | — |
| 2008 | — | Q2 | — | 2,2 | 3 | — | — | — |
| 2007 | — | Q2 | — | 2,2 | 2,6 | — | — | — |
| 2006 | — | Q2 | — | 2,4 | — | — | — | — |
| 2005 | — | Q1 | — | 2,7 | — | — | — | — |
| 2004 | — | Q2 | — | 1,7 | — | — | — | — |
| 2003 | — | Q2 | — | 2,2 | — | — | — | — |
| 2002 | — | Q2 | — | 2,2 | — | — | — | — |
| 2001 | — | Q2 | — | 2,2 | — | — | — | — |
| 2000 | — | Q2 | — | 1,7 | — | — | — | — |
| 1999 | — | Q1 | — | 2,2 | — | — | — | — |
| 1998 | — | Q1 | — | 1,9 | — | — | — | — |
| 1997 | — | Q2 | — | 1,4 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 36/100 |
| 2025 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 70/217 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 43/98 |
| 2024 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 78/213 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 37/96 |
| 2023 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 72/204 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 34/68 |
| 2022 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 63/135 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 31/67 |
| 2021 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 57/136 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 29/65 |
| 2020 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 52/133 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 23/65 |
| 2019 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 40/134 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 27/65 |
| 2018 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 44/129 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 31/65 |
| 2017 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q2 | 40/129 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 34/63 |
| 2016 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 32/127 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 32/63 |
| 2015 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 37/124 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 35/60 |
| 2014 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 43/125 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 39/65 |
| 2013 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 44/122 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 38/68 |
| 2012 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 48/120 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 36/68 |
| 2011 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 47/116 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 36/68 |
| 2010 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 48/113 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 34/61 |
| 2009 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 52/104 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 30/56 |
| 2008 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 40/92 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 27/54 |
| 2007 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 32/87 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 24/52 |
| 2006 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 25/85 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 20/51 |
| 2005 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 20/84 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 29/51 |
| 2004 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 38/84 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 19/52 |
| 2003 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 21/83 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 19/52 |
| 2002 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 23/81 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 17/50 |
| 2001 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 21/81 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 22/45 |
| 2000 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 25/80 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 18/44 |
| 1999 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 18/78 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 15/39 |
| 1998 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q1 | — | 17/79 |
| 1997 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | — | 24/75 |